Search Within

Goutam Chakraborty

Formats
  1. Journal Article (23)
  2. Meeting Abstract (22)
Groups
  1. Sloan Kettering Institute Postdocs (45)
  2. Department of Medicine (34)
  3. Genitourinary Oncology Service (34)
  4. Solid Tumor Oncology Division (34)
  5. GSK Faculty (16)
  6. Human Oncology and Pathogenesis Program (9)

More Groups

People
  1. Philip Kantoff (29)
  2. Ying Mazzu (27)
  3. Yuki Yoshikawa (22)
  4. Subhiksha Nandakumar (20)
  5. Mohammad Atiq (14)
  6. Joshua Armenia (13)

More People

Years
  1. 2024 (2)
  2. 2022 (4)
  3. 2021 (5)
  4. 2020 (7)
  5. 2019 (12)
  6. 2018 (7)

More Years

Publications
  1. Cancer Research (10)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (4)
  4. Expert Opinion on Therapeutic Targets (3)
  5. Journal of Nuclear Medicine (3)
  6. Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Clinical Oncology (10)
  3. Cell Press (4)
  4. Informa Healthcare (3)
  5. Society of Nuclear Medicine (3)
  6. FEBS Press (2)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Combined inhibition of androgen signaling and apoptosis pathways in hormone sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Jehane, L. E.; Mazzu, Y. Z.; Yoshikawa, Y.; Rajanala, S. H.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Effect of reducing specific activity of [(177)Lu]-DKFZ-PSMA617 on uptake in the tumor, salivary gland and kidney
    Meeting Abstract

    Kalidindi, T. M.; Lee, S. G.; Punzalan, B.; Veach, D.; Jou, K.; Chakraborty, G.; Tagawa, S.; Bander, N.; Lewis, J.; Larson, S.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer
    Meeting Abstract

    Yoshikawa, Y.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Chakraborty, G.; Jehane, L. E.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; Stopsack, K. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
    Meeting Abstract

    Chakraborty, G.; Ghosh, A.; Nandakumar, S.; Armenia, J.; Mazzu, Y. Z.; Atiq, M. O.; Lee, G. S. M.; Mucci, L. A.; Merghoub, T.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Checkpoint kinase inhibition in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Targeting checkpoint kinases in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Jehane, L. E.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR193b silencing activates master drivers of aggressive prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Chakraborty, G.; Yoshikawa, Y.; Nandakuma, S.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save